Levi & Korsinsky, LLP Investigates Possible Breach Of Fiduciary Duty By The Board Of InVentiv Health, Inc. - VTIV
Levi & Korsinsky is investigating the Board of Directors of inVentiv Health, Inc. (“inVentiv Health” or the “Company”) (NasdaqGS: VTIV) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to private equity firm Thomas H. Lee Partners, L.P. ("THL"). Under the terms of the transaction, inVentiv Health shareholders will receive $26.00 in cash for each inVentiv Health share of common stock they own for a total transaction value of approximately $1.1 billion.
For the quarter ending December 31, 2009, inVentiv Health reported total revenue of $274.803 million and net income of $15.947 million as compared to total revenue and net income of $270.465 million and $11.723 million, respectively, for the prior quarter. The investigation concerns whether the inVentiv Health Board of Directors breached their fiduciary duties to inVentiv Health stockholders by failing to adequately shop the Company before entering into this transaction and whether THL is underpaying for inVentiv Health shares, thus unlawfully harming inVentiv Health stockholders. At least one analyst set a price target for inVentiv Health stock at $27.00 per share.
If you own common stock in inVentiv Health and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500 or visit http://www.zlk.com/inventiv-health-vtiv.html.
Levi & Korsinsky has expertise in prosecuting investor securities
litigation and extensive experience in actions involving financial fraud
and represents investors throughout the nation, concentrating its
practice in securities and shareholder litigation.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV